Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

  1. Elez, E.
  2. Hendlisz, A.
  3. Delaunoit, T.
  4. Sastre, J.
  5. Cervantes, A.
  6. Varea, R.
  7. Chao, G.
  8. Wallin, J.
  9. Tabernero, J.
Aldizkaria:
British Journal of Cancer

ISSN: 1532-1827,  0007-0920

Argitalpen urtea: 2016

Alea: 114

Zenbakia: 4

Orrialdeak: 372-380

Mota: Artikulua

DOI: 10.1038/BJC.2015.480 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus